Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wolff

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Pharmacoeconomics|May 7, 2024
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group PerspectiveBradley M Sugden, Sabine E Grimm, Robert Wolff, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Pharmacoeconomics|January 19, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology AppraisalXavier G L V Pouwels, Robert Wolff, Bram L T Ramaekers, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinomaJane E Rogers, Alexandre A A Jácome, Aki Ohinata, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2020
Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastasesMaria-Lisa Wilhelm, Mark K H Chan, Benedikt Abel, et al.
The Cochrane Database of Systematic Reviews|August 1, 2020
Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysisNina Kreuzberger, Johanna Aag Damen, Marialena Trivella, et al.
Journal of Translational Medicine|September 16, 2018
MAGIC: once upon a time in consent management-a FHIRMartin Bialke, Thomas Bahls, Lars Geidel, et al.
Cancers|February 24, 2024
Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA ProfilingBenny Johnson, Van Morris, Xuemei Wang, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Clinical Colorectal Cancer|July 16, 2020
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall SurvivalAlexandre A Jácome, Bryan Kee, David Fogelman, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Pharmacoeconomics|May 7, 2024
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group PerspectiveBradley M Sugden, Sabine E Grimm, Robert Wolff, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Pharmacoeconomics|January 19, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology AppraisalXavier G L V Pouwels, Robert Wolff, Bram L T Ramaekers, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinomaJane E Rogers, Alexandre A A Jácome, Aki Ohinata, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2020
Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastasesMaria-Lisa Wilhelm, Mark K H Chan, Benedikt Abel, et al.
The Cochrane Database of Systematic Reviews|August 1, 2020
Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysisNina Kreuzberger, Johanna Aag Damen, Marialena Trivella, et al.
Journal of Translational Medicine|September 16, 2018
MAGIC: once upon a time in consent management-a FHIRMartin Bialke, Thomas Bahls, Lars Geidel, et al.
Cancers|February 24, 2024
Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA ProfilingBenny Johnson, Van Morris, Xuemei Wang, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Clinical Colorectal Cancer|July 16, 2020
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall SurvivalAlexandre A Jácome, Bryan Kee, David Fogelman, et al.
Pageof 13